Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000146

Options or other derivatives

  • Director acquired 36,028 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Yanai Shlomo Director 2019-12-14 Grant or award · Stock Option +28,506 28,506 D: show line 1 in the form
Yanai Shlomo Director 2019-12-14 Grant or award · Restricted Stock Units +7,522 7,522 D: show line 2 in the form
Loading xslF345X03/wf-form4_157662266649783.xml…